Summary
A great deal is now known about the mechanisms of conditioned fear acquisition and expression. More recently, the mechanisms of inhibition of conditioned fear have become the subject of intensive study. The major model system for the study of fear inhibition in the laboratory is extinction, in which a previously fear conditioned organism is exposed repeatedly to the fear-eliciting cue in the absence of any aversive event and the fear conditioned response declines. It is well established that extinction is a form of new learning as opposed to forgetting or “unlearning” of conditioned fear, and it is hypothesized that extinction develops when sensory pathways conveying sensory information to the amygdala come to engage GABAergic interneurons through forms of experience-dependent plasticity such as long-term potentiation. Several laboratories currently are investigating methods of facilitating fear extinction in animals with the hope that such treatments might ultimately prove to be useful in facilitating exposure-based therapy for anxiety disorders in clinical populations. This review discusses the advances that have been made in this field and presents the findings of the first major clinical study to examine the therapeutic utility of a drug that facilitates extinction in animals. It is concluded that extinction is an excellent model system for the study of fear inhibition and an indispensable tool for the screening of putative pharmacotherapies for clinical use.
Article PDF
Similar content being viewed by others
References
Rodrigues SM, Schafe GE, LeDoux JE. Molecular mechanisms underlying emotional learning and memory in the lateral amygdala. Neuron 44: 75–91, 2004.
Aggleton JP. The amygdala. New York: Oxford University Press, 2000.
Herman JL. Trauma and recovery. New York: BasicBooks, 1992.
Gale GD, Anagnostaras SG, Godsil BP, Mitchell S, et al. Role of the basolateral amygdala in the storage of fear memories across the adult lifetime of rats. J Neurosci 24: 3810–3815, 2004.
Rescorla RA, Wagner AR. A theory of Pavlovian conditioning: variations in the effectiveness of reinforcement and nonreinforcement. In: Classical conditioning II (Black A, Prokasy W, eds), pp 64–99. New York: Appleton-Century-Crofts, 1972.
Hawkins RD, Kandel ER. Is there a cell-biological alphabet for simple forms of learning? Psychol Rev 91: 375–391, 1984.
Robbins S. Mechanisms underlying spontaneous recovery in autoshaping. J Exp Psychol Anim Behav Process 16: 235–249, 1990.
Bouton ME, Bolles RC. Role of conditioned contextual stimuli in reinstatement of extinguished fear. J Exp Psychol Anim Behav Process 5: 368–378, 1979.
Rescorla RA, Heth CD. Reinstatement of fear to an extinguished conditioned stimulus. J Exp Psychol Anim Behav Process 1: 88–96, 1975.
McSweeney FK, Swindell S. Common processes may contribute to extinction and habituation. J Gen Psychol 129: 364–400, 2002.
Davis M, File SE. Intrinsic and extrinsic habituation and sensitization: implications for the design and interpretation of experiments. In: Habituation and the behaving organism (Peeke H, Petrinovich L, eds), pp 287–323. New York: Academic Press, 1984.
Marlin NA, Miller RR. Associations to contextual stimuli as a determinant of long-term habituation. J Exp Psychol Anim Behav Process 7: 313–333, 1981.
Bouton ME. Context, time, and memory retrieval in the interference paradigms of Pavlovian learning. Psychol Bull 114: 80–99, 1993.
Konorski J. Conditioned reflexes and neuronal organization. London: Cambridge University Press, 1948.
Pavlov I. Conditioned reflexes. Oxford: Oxford University Press, 1927.
Wagner AR. SOP: a model of automatic memory processing in animal behavior. In: Information processing in animals: memory mechanisms (Spear N, ed). Hillside, NJ: Lawrence Erlbaum Associates, 1981.
Cain CK, Blouin AM, Barad M. L-type voltage-gated calcium channels are required for extinction, but not for acquisition or expression, of conditional fear in mice. J Neurosci 22: 9113–9121, 2002.
Falls WA, Miserendino MJ, Davis M. Extinction of fear potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci 12: 854–863, 1992.
Szapiro G, Vianna MR, McGaugh JL, Medina JH, et al. The role of NMDA glutamate receptors, PKA, MAPK and CaMKII in the hippocampus in extinction of conditioned fear. Hippocampus 13: 53–58, 2003.
Santini E, Ge H, Ren K, Pena de Ortiz S, et al. Consolidation of fear extinction requires protein synthesis in the medial prefrontal cortex. J Neurosci 24: 5704–5710, 2004.
Lattal KM, Abel T. Different requirements for protein synthesis in acquisition and extinction of spatial preferences and context-evoked fear. J Neurosci 21: 5773–5880, 2001.
Repa JC, Muller J, Apergis J, Desrochers TM, et al. Two different lateral amygdala cell populations contribute to the initiation and storage of memory. Nat Neurosci 4: 724–731, 2001.
Hobin JA, Goosens KA, Maren S. Context-dependent neuronal activity in the lateral amygdala represents fear memories after extinction. J Neurosci 23: 8410–8416, 2003.
Quirk GJ, Russo GK, Barron JL, Lebron K. The role of ventro-medial prefrontal cortex in the recovery of extinguished fear. J Neurosci 20: 6225–6231, 2000.
Myers KM, Davis M. Behavioral and neural analysis of extinction. Neuron 36: 567–584, 2002.
Schafe GE, Nader K, Blair HT, LeDoux JE. Memory consolidation of Pavlovian fear conditioning: a cellular and molecular perspective. Trends Neurosci 24: 540–546, 2001.
Lin CH, Lee CC, Gean PW. Involvement of a calcineurin cascade in amygdala depotentiation and quenching of fear memory. Mol Pharmacol 63: 44–52, 2003.
Lin CH, Yeh SH, Leu TH, Chang WC, et al. Identification of calcineurin as a key signal in the extinction of fear memory. J Neurosci 23: 1574–1579, 2003.
Castellano C, McGaugh JL. Retention enhancement with posttraining picrotoxin: lack of state dependency. Behav Neural Biol 51: 165–170, 1989.
McGaugh JL, Introini-Collison IB, Nagahara AH, Cahill L, et al. Involvement of the amygdaloid complex in neuromodulatory influences on memory storage. Neurosci Biobehav Rev 14: 425–431, 1990.
Izquierdo I, Pereira ME. Post-training memory facilitation blocks extinction but not retroactive interference. Behav Neural Biol 51: 108–113, 1989.
Overton D. Experimental methods for the study of state-dependent learning. Fed Proc 33: 1800–1813, 1974.
Bouton ME, Kenney FA, Rosengard C. State-dependent fear extinction with two benzodiazepine tranquilizers. Behav Neurosci 104: 44–55, 1990.
Castellano C, McGaugh JL. Effects of post-training bicuculline and muscimol on retention: lack of state dependency. Behav Neural Biol 54: 156–164, 1990.
Harris JA, Westbrook RF. Evidence that GABA transmission mediates context-specific extinction of learned fear. Psychopharmacology (Berl) 140: 105–115, 1998.
Chhatwal JP, Myers KM, Ressler KJ, Davis M. Regulation of gephyrin and GABAA receptor binding within the amygdala after fear acquisition and extinction. J Neurosci 25: 502–506, 2005.
Ressler KJ, Paschall G, Zhou XL, Davis M. Regulation of synaptic plasticity genes during consolidation of fear conditioning. J Neurosci 22: 7892–902, 2002.
Carlson PJ, Singh JB, Zarate CA Jr, Drevets WC, Manji HK. Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets. NeuroRx 3: 22–41, 2006.
Pittenger C, Krystal JH, Coric V. Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRx 3: 69–81, 2006.
Miserendino MJD, Sananes CB, Melia KR, Davis M. Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala. Nature 345: 716–718, 1990.
Kehoe E, Macrae M, Hutchinson C. MK-801 protects conditioned response from extinction in the rabbit nictitating membrane preparation. Psychobiology 24: 127–135, 1996.
Lee H, Kim J. Amygdalar NMDA receptors are critical for new fear learning in previously fear-conditioned rats. J Neurosci 18: 8444–8454, 1998.
Baker JD, Azorlosa JL. The NMDA antagonist MK-801 blocks the extinction of Pavlovian fear conditioning. Behav Neurosci 110: 618–620, 1996.
Cox J, Westbrook R. The NMDA receptor antagonist MK-801 blocks acquisition and extinction of conditioned hypoalgesia responses in the rat. Q J Exp Psychol 47B: 187–210, 1994.
Santini E, Muller RU, Quirk GJ. Consolidation of extinction learning involves transfer from NMDA-independent to NMDA-dependent memory. J Neurosci 21: 9009–9017, 2001.
Walker DL, Ressler KJ, Lu KT, Davis M. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of d-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci 22: 2343–2351, 2002.
Ledgerwood L, Richardson R, Cranney J. Effects of d-cycloserine on extinction of conditioned freezing. Behav Neurosci 117: 341–349, 2003.
Ledgerwood L, Richardson R, Cranney J. d-Cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement. Behav Neurosci 118: 505–513, 2004.
Porter AC, Felder CC. The endocannabinoid nervous system: unique opportunities for therapeutic intervention. Pharmacol Ther 90: 45–60, 2001.
Kathuria S, Gaetani S, Fegley D, Valino F, et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9: 76–81, 2003.
Katona I, Sperlagh B, Sik A, Kafalvi A, et al. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19: 4544–4558, 1999.
Freund TF, Hajos N. Excitement reduces inhibition via endocannabinoids. Neuron 38: 362–365, 2003.
Simon AB, Gorman JM. Advances in the treatment of anxiety: targeting glutamate. NeuroRx 3: 57–68, 2006.
Haller J, Bakos N, Szirmay M, Ledent C, et al. The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Eur J Neurosci 16: 1395–1398, 2002.
Marsicano G, Wotjak CT, Azad SC, Bisogno T, et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530–534, 2002.
Chhatwal JP, Davis M, Maguschak KA, Ressler KJ. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology 30: 516–524, 2005.
Willick ML, Kokkinidis L. Cocaine enhances the expression of fear potentiated startle: evaluation of state-dependent extinction and the shock sensitization of acoustic startle. Behav Neurosci 109: 929–938, 1995.
El-Ghundi M, O’Dowd BF, George SR. Prolonged fear responses in mice lacking dopamine D1 receptor. Brain Res 892: 86–93, 2001.
Nader K, LeDoux JE. Inhibition of the mesoamygdala dopaminergic pathway impairs the retrieval of conditioned fear associations. Behav Neurosci 113: 891–901, 1999.
Ponnusamy R, Nissim HA, Barad M. Systemic blockade of D2-like dopamine receptors facilitates extinction of conditioned fear in mice. Learn Mem 12: 399–406, 2005.
McGaugh JL, Cahill L, Roozendaal B. Involvement of the amygdala in memory storage: interaction with other brain systems. Proc Natl Acad Sci USA 93: 13508–13514, 1996.
McGaugh JL. Memory—a century of consolidation. Science 287: 248–251, 2000.
Cain CK, Blouin AM, Barad M. Adrenergic transmission facilitates extinction of conditional fear in mice. Learn Mem 11: 179–187, 2004.
Berman DE, Dudai Y. Memory extinction, learning anew, and learning the new: dissociations in the molecular machinery of learning in cortex. Science 291: 2417–2419, 2001.
Bisson JI. Post-traumatic stress counselling. Br J Hosp Med 57: 112, 1997.
Mayou RA, Ehlers A, Hobbs M. Psychological debriefing for road traffic accident victims. Three-year follow-up of a randomised controlled trial. Br J Psychiatry 176: 589–593, 2000.
Rose S, Bisson JI, Churchill R, Wessely S. Psychological debriefing for preventing posttraumatic stress disorder (PTSD). Cochrane Database Syst Rev 2: CD000560, 2001.
Southwick SM, Morgan A, Nagy LM, Bremner D, et al. Trauma related symptoms in veterans of Operation Desert Storm: a preliminary report. Am J Psychiatry 150: 1524–1528, 1993.
Charney DS, Woods SW, Goodman WK, Heninger GR. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks. Am J Psychiatry 144: 1030–1036, 1987.
Southwick SM, Krystal JH, Morgan CA, Johnson D, et al. Abnormal noradrenergic function in posttraumatic stress disorder. Arch Gen Psychiatry 50: 266–274, 1993.
Ledgerwood L, Richardson R, Cranney J. d-Cycloserine facilitates extinction of learned fear: effects on reacquisition and generalized extinction. Biol Psychiatry 57: 841–847, 2005.
Rescorla RA. Effect of US habituation following conditioning. J Comp Physiol Psychol 82: 137–143, 1973.
Richardson R, Ledgerwood L, Cranney J. Facilitation of fear extinction by d-cycloserine: theoretical and clinical implications. Learn Mem 11: 510–516, 2004.
Denniston J, Chang R, Miller R. Massive extinction treatment attenuates the renewal effect. Learn Motiv 34: 68–86, 2003.
Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, et al. Cognitive enhancers as adjuncts to psychotherapy: use of d-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 61: 1136–1144, 2004.
Rothbaum BO, Hodges LF, Kooper R, Opdyke D, et al. Effectiveness of computer-generated (virtual reality) graded exposure in the treatment of acrophobia. Am J Psychiatry 152: 626–628, 1995.
Rothbaum BO, Hodges LF, Ready D, Graap K, et al. Virtual reality exposure therapy for Vietnam veterans with posttraumatic stress disorder. J Clin Psychiatry 62: 617–622, 2001.
Rothbaum BO, Schwartz AC. Exposure therapy for posttraumatic stress disorder. Am J Psychother 56: 59–75, 2002.
Rothbaum BO, Hodges L, Kooper R. Virtual reality exposure therapy. J Psychother Pract Res 6: 219–226, 1997.
Baxter M, Lanthorn T, Frick K, Golski S, et al. d-Cycloserine, a novel cognitive enhancer, improves spatial memory in aged rats. Neurobiol Aging 15: 207–213, 1994.
Quartermain D, Mower J, Rafferty M, Herting R, et al. Acute but not chronic activation of the NMDA-coupled glycine receptor with d-cycloserine facilitates learning and retention. Eur J Pharmacol 257: 7–12, 1994.
Schuster GM, Schmidt WJ. d-Cycloserine reverses the working memory impairment of hippocampal-lesioned rats in a spatial learning task. Eur J Pharmacol 224: 97–98, 1992.
Thompson LT, Moskal JR, Disterhoft JF. Hippocampus dependent learning facilitated by a monoclonal antibody or d-cycloserine. Nature 359: 638–641, 1992.
Schwartz BL, Hashtroudi S, Herting RL, Schwartz P, et al. d-Cycloserine enhances implicit memory in Alzheimer patients. Neurology 46: 420–424, 1996.
Tsai G, Falk W, Gunther J. A preliminary study of D-cycloserine treatment in Alzheimer’s disease. JNeuropsychiatry Clin Neurosci 10: 224–226, 1998.
Laake K, Oeksengaard AR. d-Cycloserine for Alzheimer’s disease. Cochrane Database Syst Rev 2: CD003153, 2002.
Randolph C, Roberts J, Tierney M, Bravi D, et al. d-Cycloserine treatment of Alzheimer’s disease. Alzheimers Dis Assoc Disord 8: 198–205, 1994.
Fakouhi T, Jhee S, Sramek J, Benes C, et al. Evaluation of cycloserine in the treatment of Alzheimer’s disease. J Geriatric Psych Neurol 8: 226–230, 1995.
Parnas AS, Weber M, Richardson R. Effects of multiple exposures to d-cycloserine on extinction of conditioned fear in rats. Neurobiol Learn Mem 83: 224–231, 2005.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Davis, M., Myers, K.M., Chhatwal, J. et al. Pharmacological treatments that facilitate extinction of fear: Relevance to psychotherapy. NeuroRX 3, 82–96 (2006). https://doi.org/10.1016/j.nurx.2005.12.008
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.nurx.2005.12.008